Combination of thermally ablative focused ultrasound with gemcitabine controls breast cancer via adaptive immunity

BACKGROUND: Triple-negative breast cancer (TNBC) remains recalcitrant to most targeted therapy approaches. However, recent clinical studies suggest that inducing tumor damage can render TNBC responsive to immunotherapy. We therefore tested a strategy for immune sensitization of murine TNBC (4T1 tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Sheybani, Natasha D, Witter, Alexandra R, Thim, Eric A, Yagita, Hideo, Bullock, Timothy N J, Price, Richard J
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical/Translational Cancer Immunotherapy
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7443308/
https://ncbi.nlm.nih.gov/pubmed/32819975
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2020-001008
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados